Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CNS Prophylaxis in Children With Acute Lymphoblastic Leukemia
NCT00019409Phase 3Withdrawn
- Sponsor
- National Institutes of Health
- Start
- Oct 1999
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of cytarabine in acute lymphoblastic leukemia (ALL), sponsored by National Institutes of Health. Planned start Oct 1999; status: withdrawn.
02
Drugs
cytarabine
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00019409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00019409.